The two companies named as defendants distribute Cold-FX products in Canada, the law firm said in a news release following the certification.
The product claims highlighted in the suit include "proven by science," and "clinically proven," as well as that they contain "clinically proven ingredients," or have a "clinically proven formula" to help reduce frequency, duration and severity of cold and flu symptoms. "The Defendants deny that they have made any false, misleading or deceptive statements in relation to COLD-FX Products and deny that they have breached any of the legislation referred to," the firm said in its news release.Those eligible to be included in the class action must have purchased one or more of the following Cold-FX products between Jan. 1, 2017, and Sept. 28, 2023, in Canada.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: blogTO - 🏆 44. / 63 อ่านเพิ่มเติม »